Read + Share
Amedeo Smart
Independent Medical Education
Mahase E. Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant. BMJ 2021;372:n296.PMID: 33526412
Email
LinkedIn
Facebook
Twitter
Privacy Policy